Diabetes

The change comes on the heels of hearings in Congress where insulin costs were held up for scrutiny.

A technology update, a new drug approval, and a drug recall due to more impurities.

Here are the top 5 articles for the month of February.

The study followed a directive from CMS to screen dialysis patients for depression and develop a follow-up plan for care for those diagnosed.

A bill would allow the importation of insulin from Canada and other countries; a survey highlighted the prevalence of anxiety and depression among teens; and the World Health Organization has established a committee to set guidelines for gene editing.

Every week, The American Journal of Managed Care® recaps the top managed care news of the week, and you can now listen to it on our podcast, Managed Care Cast.

This week, the top managed care news included increased demand for long-acting contraception since President Trump took office; a payer decision on an insulin pump alarmed diabetes advocates; and despite being involved in cancer treatment decisions, many primary care providers don't feel prepared to do so.

Every week, The American Journal of Managed Care® recaps the top managed care news of the week, and you can now listen to it on our podcast, Managed Care Cast.

This week, the top managed care news included House and Senate hearings on the cost of prescription drugs; a study finding patients with diabetes can be safely switched to cheaper insulin; and the first non-chemotherapy combination being approved for the treatment of chronic lymphocytic leukemia.

We present an International Classification of Diseases, Tenth Revision (ICD-10) translation of the adapted Diabetes Complications Severity Index and show its performance in predicting hospitalizations, mortality, and healthcare-associated costs.

The Senate Committee on Finance convened a hearing with economic and medical experts and the mother of child with insulin-dependent diabetes to discuss the burdens of high prescription drug prices and potential policy solutions that can address the rising costs without harming innovation by drug companies.

The study appeared as one of its authors testified before Congress on the high cost of prescription drugs, including insulin. Experts told the House Committee on Oversight and Reform that branded drug makers enjoy monopolies and that barriers to competition harm consumers.

Between 2012 and 2016, insulin costs for patients nearly doubled while utilization remained flat; the pharmaceutical industry's lead lobbying group spent a record amount in 2018; and alcohol-associated liver disease has surpassed hepatitis C as the top cause of liver transplants.

While depression and diabetes have been linked previously, the study from Hong Kong examined the effects of an early diagnosis of type 2 diabetes on hospitalization over time.

Every week, The American Journal of Managed Care® recaps the top managed care news of the week, and you can now listen to it on our podcast, Managed Care Cast.

This week, the top managed care news included a government shutdown affects healthcare; Democrats take control of the House; and The American Journal of Managed Care® names its most influential person in healthcare.

A statement on hypoglycemia, an consensus document from cardiologists on diabetes and CVD, and guidelines on treating cholesterol.

This week, we recapped the top news from 2018 with a look at policy changes, new research, decisions at the polls, and more.

A commentary from a cardiologist who practices in the Mississippi Delta, where a comparatively high share of the population is at risk for diabetes and peripheral artery disease.

Concerns over cost should lead FDA to recommend adjustments to these trials, which many say have led to unexpected knowledge and changed the field of diabetes care.

Leading cardiologist Mikhail N. Kosiborod, MD, FACC, FAHA, discusses how the FDA's 2008 guidance requiring cardiovascular outcomes trials has changed the treatment landscape in diabetes care and what expectations might look like going forward.

Technology and issues with reimbursement with of interest to authors writing for our diabetes journal this year.

Dublin, Ireland-based S3 Connected Health discusses the need to identify barriers to healthy behavior as well as factors that can promote healthy actions.

Every week, The American Journal of Managed Care® recaps the top managed care news of the week, and you can now listen to it on our podcast, Managed Care Cast.

An estimated 30 million Americans are living with diabetes. Additionally, 84 million have prediabetes, a condition that will result in type 2 diabetes within 5 years if not properly treated. Long regarded as one of the most prevalent chronic diseases in United States, diabetes is also a leading cause of disability and the seventh-leading cause of death. Less discussed is one of the most common complications of diabetes: diabetic foot ulcers. If not properly treated with standard and adjunctive care, these chronic wounds can lead to permanent disability and premature death.

This week, the top managed care news included a federal judge ruling that the Affordable Care Act is unconstitutional; new diabetes standards address cardiovascular risk; efforts targeting loneliness show improved health outcomes.

The relationship between diabetes management and preventing cardiovascular events was a theme throughout 2018, and this is reflected in the new standards.